Oruka Therapeutics, Inc. (ORKA)

NASDAQ: ORKA · Real-Time Price · USD

35.56

+2.24 (6.72%)

At close: Feb 24, 2026, 4:00 PM EST

35.56

0.00 (0.00%)

After-hours: Feb 24, 2026, 4:34 PM EST

Oruka Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024
Period Ending	Feb '26 Feb 24, 2026	Dec '24 Dec 31, 2024
Market Capitalization	1,721	679
Enterprise Value	1,223	325
Last Close Price	33.32	19.39
PB Ratio	3.33	1.78
P/TBV Ratio	3.56	1.79
Debt / Equity Ratio	0.00	0.00
Net Debt / Equity Ratio	-1.02	-1.03
Net Debt / EBITDA Ratio	3.99	4.12
Net Debt / FCF Ratio	5.55	6.20
Quick Ratio	16.65	28.80
Current Ratio	16.94	28.89
Return on Capital Employed (ROCE)	-25.60%	-24.90%
Earnings Yield	-4.85%	-13.46%
FCF Yield	-5.22%	-9.33%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q